These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13601859)

  • 21. Immunity following oral administration of poliomyelitis virus to monkeys.
    MELNICK JL; LEDINKO N
    J Immunol; 1951 Sep; 67(3):213-7. PubMed ID: 14888884
    [No Abstract]   [Full Text] [Related]  

  • 22. [Characteristics of the MK strain of poliomyelitis virus pathogenic for monkeys, cotton rats and newborn mice].
    MIRONOVA Lj
    Vopr Virusol; 1958; 3(2):111-4. PubMed ID: 13569983
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dynamics of multiplication of poliomyelitis virus and development of morphological changes in the central nervous system of monkeys following infection of strains C of different virulence].
    SEMENOV BF; ROZINA EE
    Vopr Virusol; 1962; 7():59-64. PubMed ID: 13910557
    [No Abstract]   [Full Text] [Related]  

  • 24. Level of serum antibody associated with intracerebral immunity in monkeys vaccinated with Lansing poliomyelitis virus.
    MORGAN IM
    J Immunol; 1949 Jul; 62(3):301-10. PubMed ID: 18132343
    [No Abstract]   [Full Text] [Related]  

  • 25. POLIOVIRUS: GUANIDINE DEPENDENCE AND LOSS OF NEUROVIRULENCE FOR MONKEYS.
    LODDO B; BROTZU G; SPANEDDA A; GESSA GL; FERRARI W
    Science; 1964 Aug; 145(3635):945-6. PubMed ID: 14163823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental infection with poliovirus type I in Taiwan monkeys by oral route.
    YANG CS; LEE YJ; LIN YC
    Taiwan Yi Xue Hui Za Zhi; 1962 Mar; 61():273-81. PubMed ID: 14002444
    [No Abstract]   [Full Text] [Related]  

  • 27. Formation of neutralizing antibody in monkeys injected with poliomyelitis virus and adjuvants.
    WARD R; RADER D; LIPTON MM; FREUND J
    Proc Soc Exp Biol Med; 1950 Jul; 74(3):536-9. PubMed ID: 15440879
    [No Abstract]   [Full Text] [Related]  

  • 28. Attempts to demonstrate interference between Coxsackie and poliomyelitis viruses in mice and monkeys.
    STANLEY NF
    Proc Soc Exp Biol Med; 1952 Nov; 81(2):430-3. PubMed ID: 13027329
    [No Abstract]   [Full Text] [Related]  

  • 29. A STUDY OF SABIN TYPE 1 ORAL VACCINE VIRUS DURING FIVE HUMAN PASSAGES.
    PAVILANIS V; LUSSIER G; FOLEY AR; CHARBONNEAU JH; DIFRANCO E; DUBREUIL R
    Rev Can Biol; 1964 Sep; 23():265-76. PubMed ID: 14237159
    [No Abstract]   [Full Text] [Related]  

  • 30. Differentiation of types of poliomyelitis viruses; reinfection experiments in monkeys (second attacks).
    BODIAN D
    Am J Hyg; 1949 Mar; 49(2):200-23. PubMed ID: 18113219
    [No Abstract]   [Full Text] [Related]  

  • 31. [Poliovirus infection in monkeys vaccinated with live Sabin vaccine].
    Beĭkin IaB; Erman BA; Vlasova LV; Vaserin IuI; Livshits AA
    Zh Mikrobiol Epidemiol Immunobiol; 1980; (2):84-9. PubMed ID: 6249057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure to demonstrate antibody in feces of monkeys vaccinated with poliomyelitis virus, Lansing strain.
    AINSLIE JD; McCALLUM JL; FRANCIS T
    Proc Soc Exp Biol Med; 1950 Dec; 75(3):699-703. PubMed ID: 14808371
    [No Abstract]   [Full Text] [Related]  

  • 33. [ON THE LOSS OF NEUTRALIZING PROPERTIES OF POLIOMYELITIS VIRUS IN THE COURSE OF ITS ADSORPTION IN EPITHELIAL KIDNEY CELLS OF M. RHESUS].
    LANGE A; ZUR HAUSEN
    Z Hyg Infektionskr; 1964 Dec; 150():179-84. PubMed ID: 14335617
    [No Abstract]   [Full Text] [Related]  

  • 34. The influence of technique on the sensitivity of monkeys to intraspinally inoculated poliovirus.
    BESWICK TS; COID CR
    J Hyg (Lond); 1961 Dec; 59(4):395-9. PubMed ID: 13868598
    [No Abstract]   [Full Text] [Related]  

  • 35. [PENETRATION OF THE POLIOMYELITIS VIRUS AND ITS MOVEMENT WITHIN THE BODY OF THE INFECTED ANIMAL. EXPERIMENTAL TRIALS ON THE CYNOMOLGUS MONKEY].
    DEBRE R; THIEFFRY S; CELERS J; DROUHET V; BOUE A; BARGETON E
    Rev Fr Etud Clin Biol; 1964 Jan; 9():27-37. PubMed ID: 14129160
    [No Abstract]   [Full Text] [Related]  

  • 36. [ON THE NEUROVIRULENCE TEST OF LIVE POLIOVIRUS VACCINES. I. BASES, TECHNIC AND EVALUATION OF THE RESEARCH ON NEUROVIRULENCE MEASUREMENT IN MONKEYS].
    BONIN O; UNTERHARNSCHEIDT F
    Arch Psychiatr Nervenkr; 1964 Nov; 206():260-71. PubMed ID: 14344120
    [No Abstract]   [Full Text] [Related]  

  • 37. Persistence of neutralizing antibody for a year following vaccination of monkeys with Lansing poliomyelitis virus.
    MORGAN IM
    Proc Soc Exp Biol Med; 1950 Nov; 75(2):305-8. PubMed ID: 14808241
    [No Abstract]   [Full Text] [Related]  

  • 38. DIFFERENTIAL SENSITIVITY OF POLIOVIRUS STRAINS TO TOLUENE.
    BALAYAN MS; PANOSYAN GA
    Acta Virol; 1965 Jan; 9():93. PubMed ID: 14299362
    [No Abstract]   [Full Text] [Related]  

  • 39. [Isolation of poliomyelitis virus strains in tissue culture, and identification in experiments on monkeys].
    FOLDES P
    Orv Hetil; 1955 Dec; 96(52):1429-33. PubMed ID: 13297466
    [No Abstract]   [Full Text] [Related]  

  • 40. Poliomyelitis in Canadian Eskimos laboratory studies. IV. Antigenic typing of virus strains in monkeys and in tissue cultures.
    WOOD W; CLARK EM; SHIMADA FT; RHODES AJ
    Can J Med Sci; 1953 Jun; 31(3):207-21. PubMed ID: 13059678
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.